Access to Galectin-3 Inhibitors from Chemoenzymatic Synthons.

J Org Chem

Université de Nantes, CNRS, Unité Fonctionnalité et Ingénierie des Protéines (UFIP), UMR 628, F-44000 Nantes, France.

Published: December 2020


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Chemoenzymatic strategies are useful for providing both regio- and stereoselective access to bioactive oligosaccharides. We show herein that a glycosynthase mutant of a α-glycosidase can react with unnatural glycosides such as 6-azido-6-deoxy-d-glucose/glucosamine to lead to β-d-galactopyranosyl-(1→3)-d-glucopyranoside or β-d-galactopyranosyl-(1→3)-2-acetamido-2-deoxy-d-glucopyranoside derivatives bearing a unique azide function. Taking advantage of the orthogonality between the azide and the hydroxyl functional groups, the former was next selectively reacted to give rise to a library of galectin-3 inhibitors. Combining enzyme substrate promiscuity and bioorthogonality thus appears as a powerful strategy to rapidly access to sugar-based ligands.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.joc.0c01927DOI Listing

Publication Analysis

Top Keywords

galectin-3 inhibitors
8
access galectin-3
4
inhibitors chemoenzymatic
4
chemoenzymatic synthons
4
synthons chemoenzymatic
4
chemoenzymatic strategies
4
strategies providing
4
providing regio-
4
regio- stereoselective
4
stereoselective access
4

Similar Publications

Background: Acute myocardial infarction in the elderly often leads to significant left ventricular structural remodeling, which adversely affects prognosis. This study aims to evaluate the effects of intensive rosuvastatin therapy on markers of ventricular remodeling and cardiac function following percutaneous coronary intervention (PCI) in elderly patients with ST-segment elevation myocardial infarction (STEMI).

Methods: This study enrolled 100 patients aged ≥60 years with STEMI who underwent emergency PCI.

View Article and Find Full Text PDF

Background: Mesenchymal stem cells (MSCs) are one of the effective treatments for acute graft-versus-host disease (aGVHD) following allogeneic hematopoietic stem cell transplantation (allo-HSCT) due to their potent immunoregulatory function. Given the limited quantity and high heterogeneity of freshly isolated MSCs, extensive expansion is essential for clinical application. Prolonged passaging of MSCs leads to a decline in therapeutic efficacy, with the underlying mechanisms remaining unclear.

View Article and Find Full Text PDF

Chitinase-3-like 1 (CHI3L1) is a secreted glycoprotein implicated in carcinogenesis and tumor immune evasion. Elevated CHI3L1 expression is frequently detected in cancer patients, highlighting it as a promising therapeutic target. To overcome the limited availability of small molecule CHI3L1 inhibitors, we established a surface plasmon resonance (SPR)-based high-throughput screening platform and applied it to a focused chemical library of small molecules.

View Article and Find Full Text PDF

Objectives: High blood levels of galectin-3 (Gal-3) predict poor outcomes after intracerebral hemorrhage (ICH). Our previous study also showed that Gal-3 could aggravate ICH-induced brain injury through increasing neuroinflammatory activation and nerve cell death. In this study, we focus on the role of Gal-3 in nerve cell death after ICH.

View Article and Find Full Text PDF

Liver cancer remains one of the leading causes of cancer-related mortality worldwide, with hepatocellular carcinoma representing its most prevalent form. This review provides a comprehensive summary of the key factors driving the initiation and progression of hepatocellular carcinoma, with a particular emphasis on immune-related mechanisms. Furthermore, we delve into the emerging roles of galectins, particularly galectin-1 and galectin-3, in hepatocellular carcinoma pathobiology, underscoring their potential utility as biomarkers for assessing disease severity and progression.

View Article and Find Full Text PDF